dc.contributorBaylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; Advantagene Inc, San Diego, CA USA; Cell Genesys Inc, Foster City, CA USA; Univ Guadalajara, CUCS, Inst Mol Biol Med, Guadalajara 44430, Jalisco, Mexico; Maxygen Inc, Redwood City, CA USA; Baylor Coll Med, Dept Radiat Oncol, Houston, TX 77030 USA; Targeted Genet Corp, Seattle, WA USA; Aventis Gencell, Preclin Oncol, Hayward, CA USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Calydon Inc, Sunnyvale, CA USA; Chiron Corp, Ctr Gene Therapy, San Diego, CA USA; Rice Univ, Dept Religious Studies, Houston, TX 77251 USA; US Oncol, Dallas, TX USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Acad Press, Mol Therapy, New York, NY USA; CUNY Mt Sinai Sch Med, Inst Gene Therapy & Mol Med, New York, NY 10029 USA
dc.creatorAguilar, LK
dc.creatorAguilar-Cordova, E
dc.creatorAndo, D
dc.creatorArmendariz-Borunda, J
dc.creatorBurd, PR
dc.creatorButler, EB
dc.creatorCarter, B
dc.creatorChiang, YL
dc.creatorGlorioso, JC
dc.creatorHenderson, DR
dc.creatorJolly, D
dc.creatorMcKenny, GP
dc.creatorNemunaitis, J
dc.creatorRives, M
dc.creatorScherer, S
dc.creatorWoo, SLC
dc.date.accessioned2015-11-19T18:55:48Z
dc.date.accessioned2022-11-02T15:28:24Z
dc.date.available2015-11-19T18:55:48Z
dc.date.available2022-11-02T15:28:24Z
dc.date.created2015-11-19T18:55:48Z
dc.date.issued2000
dc.identifier1525-0016
dc.identifierhttp://hdl.handle.net/20.500.12104/68767
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5014386
dc.languageEnglish
dc.publisherACADEMIC PRESS INC
dc.relationMOLECULAR THERAPY
dc.relation1
dc.relation5
dc.relation385
dc.relation388
dc.relationWOS
dc.titleA prescription for gene therapy
dc.typeEditorial Material


Este ítem pertenece a la siguiente institución